Mahmoud A, Choi P, Sukhwa C, Pintar J, Walch H, Zhao N
bioRxiv. 2025; .
PMID: 40027618
PMC: 11870485.
DOI: 10.1101/2025.02.17.638725.
Xu W, Xu J, Liu J, Wang N, Zhou L, Guo J
MedComm (2020). 2025; 6(3):e70119.
PMID: 40027151
PMC: 11868442.
DOI: 10.1002/mco2.70119.
Pellon-Cardenas O, Rout P, Hassan S, Fokas E, Ping H, Patel I
bioRxiv. 2025; .
PMID: 39896606
PMC: 11785226.
DOI: 10.1101/2025.01.22.634326.
Likasitwatanakul P, Li Z, Doan P, Spisak S, Raghawan A, Liu Q
bioRxiv. 2024; .
PMID: 39713466
PMC: 11661112.
DOI: 10.1101/2024.12.06.626451.
Delle Cave D, Mangini M, Tramontano C, De Stefano L, Corona M, Rea I
Int J Nanomedicine. 2024; 19:12079-12098.
PMID: 39583322
PMC: 11585298.
DOI: 10.2147/IJN.S480168.
Single-cell RNA-seq analysis of cancer-endothelial cell interactions in primary tumor and peritoneal metastasis from a single patient with colorectal cancer.
Sakimoto Y, Kumegawa K, Matsui S, Yamaguchi T, Mukai T, Okabayashi K
BJC Rep. 2024; 2(1):88.
PMID: 39558013
PMC: 11573991.
DOI: 10.1038/s44276-024-00112-3.
Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma.
Mondaza-Hernandez J, Hindi N, Fernandez-Serra A, Ramos R, Gonzalez-Campora R, Gomez-Mateo M
Ther Adv Med Oncol. 2024; 16:17588359241293951.
PMID: 39502403
PMC: 11536517.
DOI: 10.1177/17588359241293951.
Progressive plasticity during colorectal cancer metastasis.
Moorman A, Moorman A, Benitez E, Benitez E, Cambuli F, Cambulli F
Nature. 2024; 637(8047):947-954.
PMID: 39478232
PMC: 11754107.
DOI: 10.1038/s41586-024-08150-0.
Multiomic analysis of familial adenomatous polyposis reveals molecular pathways associated with early tumorigenesis.
Esplin E, Hanson C, Wu S, Horning A, Barapour N, Nevins S
Nat Cancer. 2024; 5(11):1737-1753.
PMID: 39478120
PMC: 11584401.
DOI: 10.1038/s43018-024-00831-z.
Recent Advances and Mechanism of Nanomaterials Promoting Tumor Metastasis.
Wang W, Pang X, Dong M, Li R, Liu Z, Liang Y
Environ Health (Wash). 2024; 1(6):367-382.
PMID: 39474052
PMC: 11503957.
DOI: 10.1021/envhealth.3c00132.
PLXNB1/SEMA4D signals mediate interactions between malignant epithelial and immune cells to promote colorectal cancer liver metastasis.
Xuan Z, Zhang Y, Li D, Wang K, Huang P, Shi J
J Cell Mol Med. 2024; 28(20):e70142.
PMID: 39443302
PMC: 11499074.
DOI: 10.1111/jcmm.70142.
Biantennary N-glycans As Receptors for MARTX Toxins in Pathogenesis.
Chen J, Goerdeler F, Jaroentomeechai T, Hernandez F, Wang X, Clausen H
bioRxiv. 2024; .
PMID: 39314294
PMC: 11418979.
DOI: 10.1101/2024.09.12.611726.
A Newly Developed Anti-L1CAM Monoclonal Antibody Targets Small Cell Lung Carcinoma Cells.
Yamaguchi M, Hirai S, Idogawa M, Sumi T, Uchida H, Sakuma Y
Int J Mol Sci. 2024; 25(16).
PMID: 39201435
PMC: 11354272.
DOI: 10.3390/ijms25168748.
Using deep learning to decipher the impact of telomerase promoter mutations on the dynamic metastatic morpholome.
Nevarez A, Mudla A, Diaz S, Hao N
PLoS Comput Biol. 2024; 20(7):e1012271.
PMID: 39078811
PMC: 11288469.
DOI: 10.1371/journal.pcbi.1012271.
Cell competition in primary and metastatic colorectal cancer.
van Luyk M, Krotenberg Garcia A, Lamprou M, Suijkerbuijk S
Oncogenesis. 2024; 13(1):28.
PMID: 39060237
PMC: 11282291.
DOI: 10.1038/s41389-024-00530-5.
In vivo interaction screening reveals liver-derived constraints to metastasis.
Borrelli C, Roberts M, Eletto D, Hussherr M, Fazilaty H, Valenta T
Nature. 2024; 632(8024):411-418.
PMID: 39048831
PMC: 11306111.
DOI: 10.1038/s41586-024-07715-3.
The path to leptomeningeal metastasis.
Remsik J, Boire A
Nat Rev Cancer. 2024; 24(7):448-460.
PMID: 38871881
PMC: 11404355.
DOI: 10.1038/s41568-024-00700-y.
The glutathione S-transferase Gstt1 drives survival and dissemination in metastases.
Ferrer C, Cho H, Boon R, Bernasocchi T, Wong L, Cetinbas M
Nat Cell Biol. 2024; 26(6):975-990.
PMID: 38862786
DOI: 10.1038/s41556-024-01426-7.
Mechanisms of metastatic colorectal cancer.
Canellas-Socias A, Sancho E, Batlle E
Nat Rev Gastroenterol Hepatol. 2024; 21(9):609-625.
PMID: 38806657
DOI: 10.1038/s41575-024-00934-z.
Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer.
Langerud J, Eilertsen I, Moosavi S, Klokkerud S, Reims H, Backe I
Nat Commun. 2024; 15(1):4342.
PMID: 38773143
PMC: 11109119.
DOI: 10.1038/s41467-024-48706-2.